The consortium’s objective, which has obtained €2.5 million from the Agencia Estatal de Investigación, is to advance to the clinical phase of the antifibrinolytic agent CM-352 A public-private consortium formed by the biotechnology company Hemostatics, based in the Parc Científic de Barcelona (PCB), the Clínica Universidad de Navarra (CUN), and the Institut Català d’Investigació Química […]
ICIQ molecule EADR03 for solar cells is commercialized worldwide
Dyenamo and Lumtec, chemical companies specialized in solar energy, are making the Palomares Group molecule global From ICIQ laboratories to the global market. This is the journey of the molecule EADR03, developed in the Prof. Palomares group in 2021 and published in Energy & Environmental Science journal. The Swedish chemical company Dyenamo joins the Taiwanese […]